Author： Galvani Elena Peters Godefridus J Giovannetti Elisa
Publisher： Informa Healthcare
ISSN： 1354-3784
Source： Expert Opinion on Investigational Drugs, Vol.20, Iss.10, 2011-10, pp. : 1343-1356
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Epidermal Growth Factor Receptor Inhibitors in Non-Small Cell Lung Cancer
Drugs, Vol. 67, Iss. 8, 2007-01 ,pp. :
Access to resources
Recommend
Clinical Pharmacology of EGFR/Met Inhibitors in Non-Small Cell Lung Cancer
Current Drug Targets, Vol. 15, Iss. 14, 2014-01 ,pp. :
Anaplastic Lymphoma Kinase Inhibitors in Non-Small Cell Lung Cancer
Current Drug Targets, Vol. 17, Iss. 6, 2016-05 ,pp. :
Selective Cyclooxygenase-2 Inhibitors and Non-small Cell Lung Cancer
Current Medicinal Chemistry, Vol. 9, Iss. 21, 2002-11 ,pp. :
PARP Inhibitors: An Interesting Pathway also for Non-Small Cell Lung Cancer?
Current Pharmaceutical Design, Vol. 20, Iss. 24, 2014-05 ,pp. :